US EditionPublished • loading... • Updated
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, from Thompson Street Capital Partners
Summary by Weatherford Democrat
2 Articles
2 Articles
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, from Thompson Street Capital Partners
Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout [1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics ("Isto") from Thompson Street Capital Partners ("TSCP"). TSCP will retain…
The tricolor development capital manager acquires the majority of the capital of this Massachusetts company, which is one of the leaders in orthobiology, for an amount close to $500 million.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
